Have your own idea? Try our Stock Screener
Egyptian (CASE/EGX) Healthcare Sector Analysis
UpdatedApr 09, 2026
DataAggregated Company Financials
Companies17
- 7D4.6%
- 3M2.5%
- 1Y71.0%
- YTD1.8%
In the last week, the Healthcare industry is up 4.0%, with October PharmaE up 46%. This means that the industry has gained 66% over the past year. Looking forward, earnings are forecast to grow by 32% annually.
Sector Valuation and Performance
Has the Egyptian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 Apr 2026 | ج.م95.9b | ج.م120.4b | ج.م5.4b | 21.2x | 17.8x | 0.8x |
| Sat, 07 Mar 2026 | ج.م94.7b | ج.م119.9b | ج.م5.8b | 16.5x | 16.2x | 0.8x |
| Mon, 02 Feb 2026 | ج.م90.3b | ج.م115.9b | ج.م5.5b | 15.9x | 16.4x | 0.8x |
| Wed, 31 Dec 2025 | ج.م95.5b | ج.م115.5b | ج.م5.4b | 16.6x | 17.7x | 0.8x |
| Fri, 28 Nov 2025 | ج.م85.7b | ج.م113.8b | ج.م5.1b | 16x | 16.6x | 0.8x |
| Sun, 26 Oct 2025 | ج.م94.9b | ج.م108.4b | ج.م5.1b | 17.4x | 18.5x | 0.9x |
| Tue, 23 Sep 2025 | ج.م77.8b | ج.م108.4b | ج.م5.1b | 14.8x | 15.2x | 0.7x |
| Thu, 21 Aug 2025 | ج.م66.9b | ج.م105.9b | ج.م4.7b | 15.2x | 14.3x | 0.6x |
| Sat, 19 Jul 2025 | ج.م59.1b | ج.م98.5b | ج.م4.3b | 12.1x | 13.7x | 0.6x |
| Mon, 16 Jun 2025 | ج.م53.2b | ج.م98.5b | ج.م4.3b | 11.5x | 12.4x | 0.5x |
| Wed, 14 May 2025 | ج.م56.1b | ج.م88.3b | ج.م4.0b | 8.8x | 14.2x | 0.6x |
| Fri, 11 Apr 2025 | ج.م53.1b | ج.م88.3b | ج.م3.9b | 9.1x | 13.5x | 0.6x |
| Sun, 09 Mar 2025 | ج.م50.2b | ج.م87.0b | ج.م3.8b | 13.5x | 13.3x | 0.6x |
| Tue, 04 Feb 2025 | ج.م48.7b | ج.م78.0b | ج.م3.4b | 17.7x | 14.4x | 0.6x |
| Thu, 02 Jan 2025 | ج.م46.5b | ج.م77.9b | ج.م3.4b | 18.7x | 13.9x | 0.6x |
| Sat, 30 Nov 2024 | ج.م45.6b | ج.م76.9b | ج.م3.1b | 17.2x | 14.5x | 0.6x |
| Mon, 28 Oct 2024 | ج.م46.7b | ج.م69.2b | ج.م2.9b | 9.1x | 16.2x | 0.7x |
| Wed, 25 Sep 2024 | ج.م40.0b | ج.م69.4b | ج.م2.9b | 10.1x | 13.6x | 0.6x |
| Fri, 23 Aug 2024 | ج.م34.7b | ج.م68.9b | ج.م3.1b | 7.6x | 11.2x | 0.5x |
| Sun, 21 Jul 2024 | ج.م35.1b | ج.م63.7b | ج.م3.1b | 7.6x | 11.4x | 0.6x |
| Tue, 18 Jun 2024 | ج.م33.7b | ج.م63.5b | ج.م3.1b | 7.6x | 10.8x | 0.5x |
| Thu, 16 May 2024 | ج.م31.8b | ج.م58.1b | ج.م2.4b | 10.9x | 13x | 0.5x |
| Sat, 13 Apr 2024 | ج.م36.1b | ج.م57.6b | ج.م2.9b | 8.9x | 12.7x | 0.6x |
| Mon, 11 Mar 2024 | ج.م38.7b | ج.م56.8b | ج.م2.8b | 10.5x | 13.7x | 0.7x |
| Wed, 07 Feb 2024 | ج.م36.0b | ج.م52.6b | ج.م3.0b | 10.5x | 12x | 0.7x |
| Fri, 05 Jan 2024 | ج.م33.1b | ج.م49.4b | ج.م2.7b | 8.1x | 12.4x | 0.7x |
| Sun, 03 Dec 2023 | ج.م33.2b | ج.م46.9b | ج.م2.8b | 11.3x | 12x | 0.7x |
| Tue, 31 Oct 2023 | ج.م27.5b | ج.م45.6b | ج.م2.5b | 10.6x | 10.9x | 0.6x |
| Thu, 28 Sep 2023 | ج.م25.0b | ج.م46.2b | ج.م2.6b | 10.1x | 9.6x | 0.5x |
| Sat, 26 Aug 2023 | ج.م24.4b | ج.م45.8b | ج.م2.6b | 9.8x | 9.3x | 0.5x |
| Mon, 24 Jul 2023 | ج.م25.2b | ج.م42.7b | ج.م2.6b | 9.8x | 9.7x | 0.6x |
| Wed, 21 Jun 2023 | ج.م26.4b | ج.م43.1b | ج.م2.7b | 9.5x | 9.8x | 0.6x |
| Fri, 19 May 2023 | ج.م25.4b | ج.م41.6b | ج.م2.9b | 8.9x | 8.9x | 0.6x |
| Sun, 16 Apr 2023 | ج.م25.2b | ج.م41.6b | ج.م2.9b | 8.3x | 8.7x | 0.6x |
Price to Earnings Ratio
8.7x
Current Industry PE
- Investors are optimistic on the Egyptian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 17.5x which is higher than its 3-year average PE of 13.3x.
- The industry is trading close to its 3-year average PS ratio of 0.64x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 42% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Egyptian Healthcare sector?
| EG Market | 2.80% | |
| Healthcare | 4.58% | |
| Pharma | 6.72% | |
| Healthcare Services | 1.68% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 24.2x.
- Analysts are expecting annual earnings growth of 36.4%, which is lower than the prior year's growth of 51.7% per year.
- Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 9.7x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 36% over the next 5 years.
- However this is lower than its past earnings growth rate of 52% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 26% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OCPH October PharmaE | ج.م293.17 | 50.3% +ج.م1.2b | 185.1% | PE21.3x | |
| RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) | ج.م4.42 | 7.8% +ج.م640.0m | 34.8% | PE32.9x | |
| PHAR Egyptian International Pharmaceutical Industries | ج.م82.00 | 4.5% +ج.م595.7m | 64.0% | PE11x | |
| BIOC GlaxoSmithKlineE | ج.م62.50 | 5.6% +ج.م277.3m | 72.8% | PE53.1x | |
| ISPH Ibnsina Pharma | ج.م10.40 | 2.4% +ج.م241.9m | 17.5% | PE13.6x |